This protocol provides guidance on the use of Abatacept and the processes for the safe use of the treatment in this patient group.

Abatacept is an injectable, synthetic (man-made) protein produced by recombinant DNA technology that is used for treating rheumatoid arthritis in adult patients who have had insufficient response or intolerance to other DMARDs including at least one TNF inhibitor. It is an immunosuppressant, a drug that suppresses the immune system.

BEST CARE FOR EVERYONE